Free US stock support and resistance levels with price projection models for strategic trading decisions. Our technical levels are calculated using sophisticated algorithms that identify the most significant price barriers.
Phathom Pharmaceuticals is trading near the lower end of its recent range, with the stock down about 2% on the session to $12.28. The price action shows the stock testing support just above $11.67, a level that has held in recent weeks. Resistance near $12.89 remains a key hurdle, and the failure to
Phathom Pharmaceuticals (PHAT) Stock Analysis: -2.04% Loss — Key Levels 2026-05-13 - Community Pattern Alerts
PHAT - Stock Analysis
4447 Comments
1226 Likes
1
Jung
Registered User
2 hours ago
Short-term swings are creating trading opportunities, though careful risk management is essential.
👍 264
Reply
2
Dayyan
Registered User
5 hours ago
This feels like I should remember this.
👍 296
Reply
3
Syma
Regular Reader
1 day ago
The market is demonstrating selective strength, with certain sectors outperforming while others lag.
👍 74
Reply
4
Zyara
Regular Reader
1 day ago
The market is consolidating, providing a healthy base for future moves.
👍 128
Reply
5
Mikinley
Influential Reader
2 days ago
Free US stock cash flow analysis and free cash flow yield calculations to identify companies returning value to shareholders through dividends and buybacks. Our cash flow research helps you find companies with the financial flexibility to grow their business and return capital to investors. We provide cash flow statements, free cash flow yields, and dividend sustainability analysis for comprehensive coverage. Find cash-generating companies with our comprehensive cash flow analysis and yield calculation tools for income investing.
👍 260
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.